If successful, the two chemicals or improved synthetic variations of them, could be used in combination with amiloride to treat patients in the early stages of the disease to prevent the fatal clogging of the lungs, the researchers suggested.
For two consecutive six-month periods, they used aerosol amiloride or a placebo.